Replicating success of anti-VEGF in AMD key to unlocking GA puzzle

SAN FRANCISCO — Researchers need to look to the past success of developing anti-VEGF therapies to one day find a therapy for geographic atrophy, according to a presenter here. At the American Society of Retina Specialists annual meeting, Jayakrishna Ambati, MD, discussed the need to find a therapy for geographic atrophy (GA) by looking at the path that led to the development of anti-VEGF therapies.